Zacks Investment Research
04 Jun 2026, 09:40 UTC · 1h ago
MDT Q4 Earnings Call Points to Another Year of Growth
Search tags
Zacks Investment Research
04 Jun 2026, 09:40 UTC · 1h ago
Search tags
Story key points
4 claims · impact-rated
Medtronic guided fiscal 2027 organic revenue growth to between 6.75% and 7.25% and non-GAAP EPS to $5.90–$6.00. — Forward guidance is a primary driver of stock valuation; expectations for sustained organic growth typically support a higher multiple.
+0.60Medtronic's Cardiac Ablation Solutions saw 78% growth in the quarter, while the Affera platform saw a 40% sequential increase in the U.S. installed base. — Strong growth in high-margin, innovative technology platforms indicates competitive strength and future revenue scalability.
+0.40Management has embedded an estimated $250 million tariff impact and approximately 2% dilution from M&A into its outlook. — These are explicit financial headwinds that act as a drag on margins and net profitability.
-0.30Continue reading
6 related stories
Medtronic reported Q4 adjusted earnings of $1.55 per share and revenues of $9.81 billion, both beating consensus estimates. — Earnings beats provide positive short-term sentiment and validate the company's operational execution.
+0.20Ticker attribution
Model heads
The company reported earnings beats, provided positive forward-looking guidance for fiscal 2026/2027, and showed strong growth in several key business platforms.
No ticker relationship head found.
Early access
News Impact Screener scores every headline against the stocks it moves — before the chart reacts. Join the early-access list and get alerted the moment a story hits your tickers.
Impact vectors
8 dimensions · 9 clusters
Market reaction
10 bid · 3 offered
Fool - Investing News
2h ago
